Reviewed,
UniProtKB/Swiss-Prot P50542 (PEX5_HUMAN)
Last modified
November 25, 2008.
Version 91.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Peroxisomal targeting signal 1 receptor Short name=PTS1 receptor Short name=PTS1R Alternative name(s): Peroxisome receptor 1 Peroxisomal C-terminal targeting signal import receptor PTS1-BP Peroxin-5 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 639 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Binds to the C-terminal PTS1-type tripeptide peroxisomal targeting signal (SKL-type) and plays an essential role in peroxisomal protein import. |
| Subunit structure | Interacts with PEX7 and PEX13 By similarity. Interacts with PEX12 and PEX14. |
| Subcellular location | Cytoplasm. Peroxisome membrane; Peripheral membrane protein. Note= Its distribution appears to be dynamic. It is probably a cycling receptor found mainly in the cytoplasm and as well associated to the peroxisomal membrane through a docking factor (PEX13). |
| Tissue specificity | Detected in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. |
| Involvement in disease | Defects in PEX5 are a cause of neonatal adrenoleukodystrophy (NALD) [MIM:202370]. NALD is a peroxisome biogenesis disorder (PBD) characterized by the accumulation of very long-chain fatty acids, adrenal insufficiency and mental retardation. Inheritance is autosomal recessive. Defects in PEX5 are a cause of Zellweger syndrome (ZWS) [MIM:214100]. ZWS is a fatal peroxisome biogenesis disorder characterized by dysmorphic facial features, hepatomegaly, ocular abnormalities, renal cysts, hearing impairment, profound psychomotor retardation, severe hypotonia and neonatal seizures. Death occurs within the first year of life. Defects in PEX5 may be a cause of infantile Refsum disease (IRD) [MIM:266510]. IRD is a mild peroxisome biogenesis disorder (PBD). Clinical features include early onset, mental retardation, minor facial dysmorphism, retinopathy, sensorineural hearing deficit, hepatomegaly, osteoporosis, failure to thrive, and hypocholesterolemia. The biochemical abnormalities include accumulation of phytanic acid, very long chain fatty acids (VLCFA), di- and trihydroxycholestanoic acid and pipecolic acid. |
| Sequence similarities | Belongs to the peroxisomal targeting signal receptor family. Contains 7 TPR repeats. |
Ontologies
Keywords | |
|---|---|
| Biological process | Protein transport Transport |
| Cellular component | Cytoplasm Membrane Peroxisome |
| Coding sequence diversity | Alternative splicing |
| Disease | Disease mutation Peroxisome biogenesis disorder Zellweger syndrome |
| Domain | Repeat TPR repeat |
| Technical term | 3D-structure |
Gene Ontology (GO) | |
| Biological process | protein transport Inferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | peroxisomal membrane Inferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | protein binding Ref.5 Inferred from physical interaction. Source: UniProtKB |
| Complete GO annotation... | |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P50542-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P50542-2) The sequence of this isoform differs from the canonical sequence as follows: 215-251: Missing. | ||||||
| Isoform 3 (identifier: P50542-3) The sequence of this isoform differs from the canonical sequence as follows: 283-290: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 639 | 639 | Peroxisomal targeting signal 1 receptor | PRO_0000106305 | |||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||
| Repeat | 335 – 368 | 34 | TPR 1 | ||||||||||||||||||||||||||||||||||||||||||||||
| Repeat | 369 – 402 | 34 | TPR 2 | ||||||||||||||||||||||||||||||||||||||||||||||
| Repeat | 403 – 436 | 34 | TPR 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Repeat | 452 – 485 | 34 | TPR 4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Repeat | 488 – 521 | 34 | TPR 5 | ||||||||||||||||||||||||||||||||||||||||||||||
| Repeat | 522 – 555 | 34 | TPR 6 | ||||||||||||||||||||||||||||||||||||||||||||||
| Repeat | 556 – 589 | 34 | TPR 7 | ||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 215 – 251 | 37 | Missing in isoform 2. | VSP_021880 | |||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 283 – 290 | 8 | Missing in isoform 3. | VSP_024106 | |||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 526 | 1 | N → K in NALD; strongly affects peroxisomal protein import. | VAR_007543 | |||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 600 | 1 | S → W in IRD; mildly affects peroxisomal protein import. | VAR_031328 | |||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 118 | 1 | W → A: Strongly reduced interaction with PEX14 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 122 | 1 | F → A: Strongly reduced interaction with PEX14 | ||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 425 | 1 | T → I in AAC50103. Ref.1 | ||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 318 – 321 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 331 – 334 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 338 – 347 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 351 – 363 | 13 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 369 – 381 | 13 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 385 – 398 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 403 – 415 | 13 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 419 – 431 | 13 | |||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 434 – 436 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 437 – 439 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 460 – 481 | 22 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 488 – 500 | 13 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 504 – 517 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 522 – 534 | 13 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 538 – 551 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 556 – 569 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 572 – 587 | 16 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 601 – 614 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 617 – 619 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 620 – 624 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 628 – 634 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders." Dodt G., Braverman N., Wong C., Moser A., Moser H.W., Watkins P., Valle D., Gould S.J. Nat. Genet. 9:115-125(1995) [PubMed: 7719337] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), INVOLVEMENT IN ZWS, VARIANT NALD LYS-526, FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [2] | "Human peroxisomal targeting signal-1 receptor restores peroxisomal protein import in cells from patients with fatal peroxisomal disorders." Wiemer E.A.C., Nuttley W.M., Bertolaet B.L., Li X., Francke U., Wheelock M.J., Anne U.K., Johnson K.R., Subramani S. J. Cell Biol. 130:51-65(1995) [PubMed: 7790377] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, TISSUE SPECIFICITY. Tissue: Liver. |
| [3] | "Identification and characterization of the putative human peroxisomal C-terminal targeting signal import receptor." Fransen M., Brees C., Baumgart E., Vanhooren J.C.T., Baes M., Mannaerts G.P., van Veldhoven P.P. J. Biol. Chem. 270:7731-7736(1995) [PubMed: 7706321] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION. Tissue: Liver. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Eye. |
| [5] | "PEX12 interacts with PEX5 and PEX10 and acts downstream of receptor docking in peroxisomal matrix protein import." Chang C.C., Warren D.S., Sacksteder K.A., Gould S.J. J. Cell Biol. 147:761-774(1999) [PubMed: 10562279] [Abstract] Cited for: INTERACTION WITH PEX12. |
| [6] | "The di-aromatic pentapeptide repeats of the human peroxisome import receptor PEX5 are separate high affinity binding sites for the peroxisomal membrane protein PEX14." Saidowsky J., Dodt G., Kirchberg K., Wegner A., Nastainczyk W., Kunau W.-H., Schliebs W. J. Biol. Chem. 276:34524-34529(2001) [PubMed: 11438541] [Abstract] Cited for: INTERACTION WITH PEX14, MUTAGENESIS OF TRP-118 AND PHE-122. |
| [7] | "Peroxisomal targeting signal-1 recognition by the TPR domains of human PEX5." Gatto G.J. Jr., Geisbrecht B.V., Gould S.J., Berg J.M. Nat. Struct. Biol. 7:1091-1095(2000) [PubMed: 11101887] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 272-639 IN COMPLEX WITH TARGETING PEPTIDE. |
| [8] | "Recognition of a functional peroxisome type 1 target by the dynamic import receptor pex5p." Stanley W.A., Filipp F.V., Kursula P., Schuller N., Erdmann R., Schliebs W., Sattler M., Wilmanns M. Mol. Cell 24:653-663(2006) [PubMed: 17157249] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 321-639 IN COMPLEX WITH TARGETING PEPTIDE. |
| [9] | "Functional heterogeneity of C-terminal peroxisome targeting signal 1 in PEX5-defective patients." Shimozawa N., Zhang Z., Suzuki Y., Imamura A., Tsukamoto T., Osumi T., Fujiki Y., Orii T., Barth P.G., Wanders R.J., Kondo N. Biochem. Biophys. Res. Commun. 262:504-508(1999) [PubMed: 10462504] [Abstract] Cited for: VARIANT NALD LYS-526, VARIANT IRD TRP-600, CHARACTERIZATION OF VARIANT NALD LYS-526, CHARACTERIZATION OF VARIANT IRD TRP-600. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U19721 mRNA. Translation: AAC50103.1. Z48054 mRNA. Translation: CAA88131.1. X84899 mRNA. Translation: CAA59324.1. BC010621 mRNA. Translation: AAH10621.1. | |||||||||||||||||||||||||||||||
| PIR | A56126. | ||||||||||||||||||||||||||||||
| RefSeq | NP_001124497.1. NP_001124498.1. | ||||||||||||||||||||||||||||||
| UniGene | Hs.567327 | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||
| IntAct | P50542. | ||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||
| PhosphoSite | P50542. | ||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||
| Ensembl | ENSG00000139197. Homo sapiens. [Contig view] | ||||||||||||||||||||||||||||||
| GeneID | 5830. | ||||||||||||||||||||||||||||||
| KEGG | hsa:5830. | ||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||
| H-InvDB | HIX0010397. | ||||||||||||||||||||||||||||||
| HGNC | HGNC:9719. PEX5. | ||||||||||||||||||||||||||||||
| MIM | 202370. phenotype. 214100. phenotype. 266510. phenotype. 600414. gene. | ||||||||||||||||||||||||||||||
| Orphanet | 44. Adrenoleukodystrophy, neonatal. 772. Refsum disease, infantile form. 912. Zellweger syndrome. | ||||||||||||||||||||||||||||||
| PharmGKB | PA34063. | ||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||
| GeneCards | Search... | ||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||
| HOVERGEN | P50542. | ||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||
| ArrayExpress | P50542. | ||||||||||||||||||||||||||||||
| CleanEx | HS_PEX5. | ||||||||||||||||||||||||||||||
| GermOnline | ENSG00000139197. Homo sapiens. | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| InterPro | IPR001440. TPR-1. IPR013026. TPR_region. [Graphical view] | ||||||||||||||||||||||||||||||
| Pfam | PF00515. TPR_1. 4 hits. [Graphical view] | ||||||||||||||||||||||||||||||
| SMART | SM00028. TPR. 4 hits. [Graphical view] | ||||||||||||||||||||||||||||||
| PROSITE | PS50005. TPR. 5 hits. PS50293. TPR_REGION. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Other Resources | |||||||||||||||||||||||||||||||
| LinkHub | P50542. | ||||||||||||||||||||||||||||||
| NextBio | 22716. | ||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||
Entry information
| Entry name | PEX5_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P50542 Secondary accession number(s): Q15115, Q15266, Q96FN7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with